Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: Difference-in-differences analysis

BMJ (Online)

Volumn 346, Issue 7896, 2013, Pages

  King, Marissa ^a   Essick, Connor ^a   Bearman, Peter ^b   Ross, Joseph S ^c  

^a YALE SCHOOL OF MANAGEMENT   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESVENLAFAXINE; LISDEXAMFETAMINE; PALIPERIDONE; PSYCHOTROPIC AGENT;

ARTICLE; CONFLICT OF INTEREST; CONTROLLED STUDY; DRUG MARKETING; GIFT GIVING; HEALTH CARE POLICY; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SCHOOL; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOHEXANOLS; DEXTROAMPHETAMINE; DRUG INDUSTRY; GIFT GIVING; HEALTH CARE SECTOR; HUMANS; INTERPROFESSIONAL RELATIONS; ISOXAZOLES; MARKETING OF HEALTH SERVICES; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; PYRIMIDINES; SCHOOLS, MEDICAL; UNITED STATES;

EID: 84874317142     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f264     Document Type: Article

References (18)

1. American Medical Student Association. Executive summary 2012. www.amsascorecard. org/executive-summary.
2. American Medical Association. Gifts to physicians from industry. Council on Ethical and Judicial Affairs, American Medical Association; March 2008. www.ama-assn.org/ama/pub/category/4001.html.
3. Association of American Medical Colleges. Industry funding of medical education. Association of American Medical Colleges, 2008.
4. Advanced Medical Technology Association. Code of ethics on interactions with health care professionals. 2008. www.advamed.org/NR/rdonlyres/61D30455- F7E9-4081-B219-12D6CE347585/0/ AdvaMedCodeofEthicsRevisedandRestatedEffective20090701.pdf.
5. Pharmaceutical Research and Manufacturers of America. Code on interactions with healthcare professionals. Pharmaceutical Research and Manufacturers of America, 2008. www.phrma.org/files/ PhRMA%20Marketing%20Code%202008.pdf.
6. Austad KE, Avorn J, Kesselheim AS. Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review. PLoS Med 2011;8:e1001037.
7. Sierles FS, Brodkey AC, Cleary LM, McCurdy FA, Mintz M, Frank J, et al. Medical students' exposure to and attitudes about drug company interactions. JAMA 2005;294:1034-42. (Pubitemid 41248444)
8. Manchanda P, Xie Y, Youn N. The role of targeted communication and contagion in product adoption. Mark Sci 2008;27:961-76.
9. Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MCJM, Haaijer-Ruskamp FM. Determinants for the adoption of angiotensin II receptor blockers by general practitioners. Soc Sci Med 2006;63:2890-8. (Pubitemid 44584502)
10. Fugh-Berman AJ, Scialli AR, Bell AM. Why lunch matters: assessing physicians' perceptions about industry relationships. J Contin Educ Health Prof 2010;30:197-204.
11. Kao A, Braddock C, Clay M, Elliott D, Epstein S, Filstead W, et al. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study. Acad Med 2011;86:1454-62.
12. Grande D, Frosch DL, Perkins A, Kahn BE. Effect of exposure to small pharmaceutical promotional items on treatment preferences. Arch Intern Med 2009;169:887-93.
13. McCormick B, Tomlinson G, Brill-Edwards P, Detsky A. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001;286:1994-9. (Pubitemid 33010218)
14. American Medical Association. AMA physcian masterfile. 2012. www.ama-assn.org/ama/pub/about-ama/physician-data-resources/physician- masterfile.page?
15. Institute of Medicine as a Profession. Academic medical centers and conflict of interest. 2012. www.imapny.org/conflicts-of-interest/conflicts-of- interest-overview/amcs.
16. IMS National Sales Perspectives. 2008 U.S. sales and prescription information: top therapuetic classes by U.S. sales. 2008. www.imshealth.com/ deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top- line%20Market%20Data/2008%20Top-line% 20Market%20Data/2008-Top-Therapy-Classes- by-U.S.-Sales.pdf.
17. Vermont Attorney General. Pharmacuetical marketing disclosures: report of the Attorney General William H Sorrell. 2010. www.atg.state.vt.us/assets/files/ FY09%20Final% 20Pharma%20Disclosure%20Report.pdf.
18. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2010;290:252-5.